Bivalent RSV Prefusion F Vaccine in Older Adults | NEJM

Опубликовано: 02 Октябрь 2024
на канале: NEJM Group
4,469
43

Respiratory syncytial virus infection causes substantial illness in older adults. A bivalent RSV prefusion F vaccine is under investigation to reduce RSV-associated respiratory illness.

New research findings are summarized in this short video.

To see full article, follow this link: https://nej.md/40zX0xf